Lessons from nature, #genomics that triglycerides-> coronary artery disease http://t.co/veXB0hMwqK [not = to Rx TG to prevent CAD]
— Eric Topol (@EricTopol) October 6, 2013
From organ replacement medicine to genomic precision medicine. Documenting all the way from Organ Donation to Gene Editing: The "Creative Destruction of Medicine". Organ replacement technologies. 3D Bioprinting. Fablabs. DIY Bio. New-Gen Genome Sequencing. Gene Therapy (transplanting genes into cells, rewriting patients' DNA). MOOCs. mHealth. In Memoriam Pr. Emmanuel Andronikof, Mathematician, Steve Jobs: "Think different," and Aaron Swartz: "Access to information is a human right."
Informations sur ce blog - Mes favoris
▼
Triglyceride-rich lipoproteins causally influence risk for coronary artery disease
"Triglycerides are transported in plasma by specific triglyceride-rich
lipoproteins; in epidemiological studies, increased triglyceride levels
correlate with higher risk for coronary artery disease (CAD). However,
it is unclear whether this association reflects causal processes. We
used 185 common variants recently mapped for plasma lipids (P < 5 × 10−8
for each) to examine the role of triglycerides in risk for CAD. First,
we highlight loci associated with both low-density lipoprotein
cholesterol (LDL-C) and triglyceride levels, and we show that the
direction and magnitude of the associations with both traits are factors
in determining CAD risk. Second, we consider loci with only a strong
association with triglycerides and show that these loci are also
associated with CAD. Finally, in a model accounting for effects on LDL-C
and/or high-density lipoprotein cholesterol (HDL-C) levels, the
strength of a polymorphism's effect on triglyceride levels is correlated
with the magnitude of its effect on CAD risk. These results suggest
that triglyceride-rich lipoproteins causally influence risk for CAD." (http://www.nature.com/ng/journal/vaop/ncurrent/abs/ng.2795.html)
Aucun commentaire:
Enregistrer un commentaire